Noveome Biotherapeutics

Clinical-stage biopharmaceutical company

Based in PA

🤖

AI Overview

With $100K in lobbying spend across 3 quarterly filings, Noveome Biotherapeutics is an active lobbying client. Their lobbying covers 2 issue areas.

$100K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$100K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Noveome Biotherapeutics disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)White House Office
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED

Communications on behalf of Noveome Biotherapeutics; pending clinical issues before the FDA; COVID-19 pandemic related issues before Congress and the Development Finance Corporation.

Pending clinical issues before the FDA; COVID-19 pandemic related issues before Congress and the Development Finance Corporation.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.